Earnings Call · Q1 FY2026·2026-05-14

Q1 26EPS +6.06%·Rev n/aQ4 25EPS -78.24%·Rev n/aQ3 25EPS +100.00%*·Rev n/aQ2 25EPS +40.00%·Rev n/a⚠ consensus missing

CorMedix Inc. CRMD

Daniel Ferry — Investor Relations

Joseph Todisco — Chief Executive Officer

Elizabeth Masson-Hurlburt — EVP and Chief Operating Officer

Susan Blum — Chief Financial Officer

+5.7%1d on move date+4.9% vs SPY3d+5.5%5d+5.7%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CRMD calls or request research access.

More CRMD calls Browse calls Request research access